PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Aug-2022 Tardive Dyskinesia (TD) Treatment Drugs Market Report 2022: Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2029 - ResearchAndMarkets.com Businesswire
12-Aug-2022 Anti-Epileptic Drugs Market Report 2022: Increasing Awareness About Treatment With Anti-Epileptic Drugs, Patent Expiration and Approval of Pipeline Products to Drive Growth - ResearchAndMarkets.com Businesswire
12-Aug-2022 More German Firms Seek IoT Services for Competitive Edge Businesswire
12-Aug-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Aug-2022 Eurofins Strengthens Its Comprehensive Food Testing Offering in Japan Through the Acquisition of QSAI Analysis and Research Center Co.,Ltd. Businesswire
12-Aug-2022 Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update Businesswire
11-Aug-2022 VistaGen Therapeutics Reports First Quarter Financial Results and Provides Corporate Update Businesswire
11-Aug-2022 Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update Businesswire
11-Aug-2022 Aura Biosciences Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights Businesswire
11-Aug-2022 Applied DNA Reports Third Quarter Fiscal 2022 Financial Results Businesswire
11-Aug-2022 Amneal launches 4 new Generic products, including Vasopressin single-dose Businesswire
11-Aug-2022 Owlet Announces Second Quarter 2022 Financial Results Businesswire
11-Aug-2022 Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2022 Financial Results Businesswire
11-Aug-2022 Lineage Cell Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update Businesswire
11-Aug-2022 Veracyte Appoints Eliav Barr, M.D., to Its Board of Directors Businesswire
11-Aug-2022 Kezar Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update Businesswire
11-Aug-2022 Genentech Announces FDA Approval of Xofluza to Treat Influenza in Children Aged Five and Older Businesswire
11-Aug-2022 NextRNA Therapeutics Names Dominique Verhelle as CEO and Expands Leadership Team Businesswire
11-Aug-2022 Cullgen Announces Chinese NMPA Allowance of Investigational New Drug Application of TRK Degrader to Begin Clinical Trials Businesswire
11-Aug-2022 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avaya Holdings Corp. (AVYA) on Behalf of Investors Businesswire